.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Citi
Boehringer Ingelheim
Moodys
UBS
Federal Trade Commission
Daiichi Sankyo
Chubb
Cantor Fitzgerald
Medtronic

Generated: December 15, 2017

DrugPatentWatch Database Preview

Acs Dobfar Company Profile

« Back to Dashboard

What is the competitive landscape for ACS DOBFAR, and what generic and branded alternatives to ACS DOBFAR drugs are available?

ACS DOBFAR has twenty-five approved drugs.



Summary for Acs Dobfar

US Patents:0
Tradenames:16
Ingredients:14
NDAs:25
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Acs DobfarCEFTAZIDIMEceftazidimeINJECTABLE;INJECTION062640-002Nov 20, 1985APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarCEFTAZIDIMEceftazidimeINJECTABLE;INJECTION062640-004Feb 3, 1992APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarKEFZOLcefazolin sodiumINJECTABLE;INJECTION061773-004Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarCEFOXITINcefoxitin sodiumINJECTABLE;INJECTION065414-002Jun 12, 2009APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Acs Dobfar SpaCEFUROXIME SODIUMcefuroxime sodiumINJECTABLE;INJECTION064124-001May 30, 1997APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarKEFZOLcefazolin sodiumINJECTABLE;INJECTION061773-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs Dobfar SpaAMPICILLIN SODIUMampicillin sodiumINJECTABLE;INJECTION090884-003Apr 3, 2013APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarCEFEPIME HYDROCHLORIDEcefepime hydrochlorideINJECTABLE;INJECTION065441-001Mar 20, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarAMPICILLIN AND SULBACTAMampicillin sodium; sulbactam sodiumINJECTABLE;INJECTION065406-001Dec 22, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Acs DobfarKEFZOLcefazolin sodiumINJECTABLE;INJECTION061773-005Sep 8, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Federal Trade Commission
Novartis
Baxter
Merck
QuintilesIMS
Mallinckrodt
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot